Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cardiokol's primary focus?
- Cardiokol is a digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations.
- When was Cardiokol founded?
- Cardiokol was founded in August 2017.
- How much funding has Cardiokol raised in total?
- Cardiokol has raised a total of $8,000,000 USD.
- Which investors participated in Cardiokol's Seed round?
- In September 2019, Cardiokol's Seed round included lead investor Kamet Ventures, and also KYTO.
- What is the approximate employee count for Cardiokol?
- Cardiokol has 9 employees.
- What are the primary geographic markets for Cardiokol?
- Cardiokol's primary geographic markets are the United States and Europe.
- What type of technology does Cardiokol utilize?
- Cardiokol utilizes proprietary technology implemented in speech platforms, including Artificial Intelligence, Machine Learning, Voice & Speech Recognition, Semiconductors & Electronics, and Digital Signal Processor.
- Has Cardiokol received any grants?
- Cardiokol has received a grant from the IIA.
- What was a notable partnership for Cardiokol in late 2021?
- In November 2021, Cardiokol joined Bayer's G4A program, as reported by MobiHealthNews.